Behavioral characterization of mouse models for Smith-Magenis syndrome and dup(17)(p11.2p11.2)

被引:60
作者
Walz, K
Spencer, C
Kaasik, K
Lee, CC
Lupski, JR
Paylor, R [1 ]
机构
[1] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
[2] Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA
[3] Texas Childrens Hosp, Houston, TX 77030 USA
关键词
D O I
10.1093/hmg/ddh044
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Contiguous gene syndromes (CGS) refer to a group of disorders associated with chromosomal rearrangements in which the phenotype is thought to result from altered copy number of physically linked dosage-sensitive genes. Smith-Magenis syndrome and [dup(17)(p11.2p11.2)] are CGS associated with a heterozygous deletion or duplication of band p11.2 of chromosome 17, respectively. We previously constructed animal models for these CGSs by engineering rearranged chromosomes carrying a deletion/deficiency [Df(11)17] (Del mutant) or a duplication [Dp(11)17 ] (Dup mutant) of the syntenic region on mouse chromosome 11. Here we present a behavioral analysis of these models indicating that heterozygous male mice carrying the engineered deletion or the duplication are hypoactive or hyperactive, respectively. In addition, male Dup mutant mice, but not Del mutant mice, have impaired contextual fear conditioning. Circadian rhythm studies revealed period length differences in Del mutant mice, but not Dup mutant mice. These results indicate that some of the behavioral abnormalities are gene dosage sensitive, whereas other behavioral abnormalities are specific to mice carrying the deletion or the duplication and can be observed in a sex preferential manner. Our findings suggest that there is a gene(s) present in this defined genomic interval that is responsible for behavioral abnormalities in the mouse, as has been shown for the human syntenic region.
引用
收藏
页码:367 / 378
页数:12
相关论文
共 33 条
[1]
[Anonymous], METABOLIC MOL BASIS
[2]
Genes in a refined Smith-Magenis syndrome critical deletion interval on chromosome 17p11.2 and the syntenic region of the mouse [J].
Bi, WM ;
Yan, J ;
Stankiewicz, P ;
Park, SS ;
Walz, K ;
Boerkoel, CF ;
Potocki, L ;
Shaffer, LG ;
Devriendt, K ;
Nowaczyk, MJM ;
Inoue, K ;
Lupski, JR .
GENOME RESEARCH, 2002, 12 (05) :713-728
[3]
Attention deficit disorder: A review of the past 10 years [J].
Cantwell, DP .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1996, 35 (08) :978-987
[4]
Homologous recombination of a flanking repeat gene cluster is a mechanism for a common contiguous gene deletion syndrome [J].
Chen, KS ;
Manian, P ;
Koeuth, T ;
Potocki, L ;
Zhao, Q ;
Chinault, AC ;
Lee, CC ;
Lupski, JR .
NATURE GENETICS, 1997, 17 (02) :154-163
[5]
5 CASES DEMONSTRATING THE DISTINCTIVE BEHAVIORAL FEATURES OF CHROMOSOME DELETION 17(P11.2 P11.2) (SMITH-MAGENIS SYNDROME) [J].
COLLEY, AF ;
LEVERSHA, MA ;
VOULLAIRE, LE ;
ROGERS, JG .
JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 1990, 26 (01) :17-21
[6]
A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice [J].
Crawley, JN ;
Paylor, R .
HORMONES AND BEHAVIOR, 1997, 31 (03) :197-211
[7]
Inversion of the circadian rhythm of melatonin in the Smith-Magenis syndrome [J].
De Leersnyder, H ;
de Blois, MC ;
Claustrat, B ;
Romana, S ;
Albrecht, U ;
von Kleist-Retzow, JC ;
Delobel, B ;
Viot, G ;
Lyonnet, S ;
Vekemans, M ;
Munnich, A .
JOURNAL OF PEDIATRICS, 2001, 139 (01) :111-116
[8]
β1-adrenergic antagonists improve sleep and behavioural disturbances in a circadian disorder, Smith-Magenis syndrome [J].
De Leersnyder, H ;
de Blois, MC ;
Vekemans, M ;
Sidi, D ;
Villain, E ;
Kindermans, C ;
Munnich, A .
JOURNAL OF MEDICAL GENETICS, 2001, 38 (09) :586-590
[9]
Brief report: Cognitive and behavioral profiles in persons with Smith-Magenis syndrome [J].
Dykens, EM ;
Finucane, BM ;
Gayley, C .
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 1997, 27 (02) :203-211
[10]
FINUCANE BM, 1994, DEV MED CHILD NEUROL, V36, P78